Patents Assigned to Quadrant Technology
  • Patent number: 12228131
    Abstract: An integrated electric oil pump includes a pump housing, in which a motor and a gerotor in the motor are arranged, a ball bearing is arranged between the motor and the gerotor, the motor includes a stator assembly and a motor rotor, the gerotor includes an inner gear, an outer gear and a pin, the hollow motor rotor is installed within the stator assembly, the outer gear is arranged in the motor rotor and is integrated with the motor rotor, a shaft sleeve is installed at a center of the motor rotor, the pin is arranged inside the shaft sleeve, the inner gear is arranged outside the shaft sleeve, the inner gear and the pin are respectively in press fit with the shaft sleeve, and the inner gear is engaged with the outer gear.
    Type: Grant
    Filed: April 18, 2024
    Date of Patent: February 18, 2025
    Assignee: HANGZHOU QUADRANT TECHNOLOGY CO., LTD.
    Inventors: Liping Wang, Guojun Zhang, Ruinan Wang, Hezhao Hua, Yi Zhao
  • Patent number: 12140141
    Abstract: The present application discloses a high-precision electric oil pump, which relates to the technical field of new energy vehicles. The electric oil pump includes a pump housing connected with an outer gear and an inner gear engaged with each other, the pump housing is internally connected to a fixed shaft concentrically arranged with the pump housing, the outer gear is connected to the fixed shaft and concentrically arranged with the pump housing, the fixed shaft includes a connecting section, an eccentric calibrator is provided on an outer circumferential wall of the connecting section, the eccentric calibrator and the connecting section form an eccentric assembly, the inner gear is rotated around a geometric central axis of the eccentric assembly, and the eccentric assembly is non-concentrically arranged with the pump housing.
    Type: Grant
    Filed: April 30, 2024
    Date of Patent: November 12, 2024
    Assignee: HANGZHOU QUADRANT TECHNOLOGY CO., LTD.
    Inventors: Liping Wang, Guojun Zhang, Ruinan Wang, Hezhao Hua, Yi Zhao, Zhixue Lu
  • Patent number: 12057261
    Abstract: The present application relates to the technical field of electromagnetic-isolation shielding materials, and in particular to a heat-resistant nanocrystalline magnetic-isolation shielding material and a preparation method and application thereof. The preparation method includes the following steps: S1, applying a double-sided adhesive tape onto a nanocrystalline soft-magnetic alloy ribbon to prepare a adhesive-coated nanocrystalline ribbon; S2, performing primary magnet cracking treatment on the adhesive-coated nanocrystalline ribbon to obtain a single-layered nanocrystalline magnetic layer; S3, performing multi-layer combination on the single-layered nanocrystalline magnetic layer to obtain a composite, and performing stress relief treatment on the composite to obtain a multi-layered nanocrystalline magnetic layer; and S4: performing secondary magnet cracking treatment on the multi-layered nanocrystalline magnetic layer to obtain a heat-resistant nanocrystalline magnetic-isolation shielding material.
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: August 6, 2024
    Assignee: HANGZHOU QUADRANT TECHNOLOGY CO., LTD.
    Inventors: Zhijian Liu, Chengliang Ni, Li Feng, Guwei Wang, Dan Xia
  • Patent number: 8047203
    Abstract: A unit dose dry powder inhaler has a dispersion chamber, optionally including one or more beads. A blister is supported adjacent to the dispersion chamber. A mouthpiece cover is removable from a mouthpiece, with movement of the mouthpiece cover causing the blister to open. An air flow path extends past or under the blister and into the dispersion chamber. As a result, the blister remains sealed until the inhaler is ready for use. The blister is then automatically opened when the mouthpiece cover is removed from the mouthpiece. Pharmaceutical dry powder is released from the blister and entrained in air flow through the inhaler, when the user inhales on the mouthpiece. The powder is dispersed in air within the dispersion chamber.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: November 1, 2011
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew E. Young, Stuart Brian William Kay, Neil R Harrison
  • Patent number: 7958890
    Abstract: A dry powder inhaler has a dispersion chamber containing beads. A dose of dry powder is released into the chamber, or into an inlet tangentially joining into the chamber. As the patient inhales on a nosepiece or mouthpiece, air moves circularly through the dispersion chamber to drive the beads. The beads roll, bounce, and collide repeatedly with the drug particles on the chamber surfaces or on the beads. The smaller active drug particles are separated from larger carrier particles and from each other, and a powder aerosol is created and inhaled by the patient. The beads are preferably lightweight, so that they can be rapidly accelerated and moved, even with nominal inspiration. The flow resistance of the inhaler is also reduced via the beads, allowing greater airflow and powder dispersion, without any increased effort by the patient.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: June 14, 2011
    Assignee: Quadrant Technologies Limited
    Inventors: Andrew W. Gieschen, Michael Ligotke, Jeffrey Chen, Charles F. Ganem, Bernard Greenspan
  • Patent number: 7556035
    Abstract: A unit dose dry powder inhaler includes a chamber housing containing a powder dispersion chamber. A chamber tube extends from the dispersion chamber into the mouthpiece. A cover or cup is rotatably attached to the chamber housing. A dose of a dry powder is contained at a powder location in the chamber housing. An air passageway leading from the powder location to the dispersion chamber is closed off by the cover. When the cover is rotated to an open position, the air passageway is opened. The user inhales on the mouthpiece drawing air through the powder location, the air passageway, the dispersion chamber and the chamber tube, through the mouthpiece and into the users lungs. The unit dose of dry powder is stored directly in, or is part of, the inhaler.
    Type: Grant
    Filed: May 17, 2005
    Date of Patent: July 7, 2009
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew E. Young, Stuart Brian William Kay, Neil Richard Harrison, Michael W. Ligotke
  • Patent number: 7069929
    Abstract: A dry powder inhaler includes an actuator pivotably mounted on a base. Movement of the actuator from a first position to a second position drives the a dobber to open a blister. A dispersion engine sub-assembly has a blister hood positioned over a blister opening position. A powder pathway connects from the blister hood into a powder dispersion engine. Upon inhalation, air flow draws powder up and out of an opened blister, into the blister hood and to the powder dispersion engine. Movement of the actuator causes the dobber to shear open a blister and also to press the blister hood down over the blister. This increases air flows up and around the open blister, carrying the pharmaceutical powder up and out of the blister and into the dispersion engine.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: July 4, 2006
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew Young, Stuart Kay, Neil Harrison, James Welsh, Michael Ligotke
  • Patent number: 6971384
    Abstract: A dry powder inhaler has a dispersion chamber containing beads. A dose of dry powder is released into the chamber, or into an inlet tangentially joining into the chamber. As the patient inhales on a nosepiece or mouthpiece, air moves circularly through the dispersion chamber to drive the beads. The beads roll, bounce, and collide repeatedly with the drug particles on the chamber surfaces or on the beads. The smaller active drug particles are separated from larger carrier particles and from each other, and a powder aerosol is created and inhaled by the patient. The beads are preferably lightweight, so that they can be rapidly accelerated and moved, even with nominal inspiration. The flow resistance of the inhaler is also reduced via the beads, allowing greater airflow and powder dispersion, without any increased effort by the patient.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: December 6, 2005
    Assignee: Quadrant Technologies Limited
    Inventors: Andrew W. Gieschen, Michael Ligotke, Jeffrey Chen, Charles Ganem, Bernard Greenspan
  • Patent number: 6941947
    Abstract: A unit dose dry powder inhaler has a dispersion chamber, optionally including one or more beads. A blister is supported adjacent to the dispersion chamber. A mouthpiece cover is removable from a mouthpiece, with movement of the mouthpiece cover causing the blister to open. An air flow path extends past or under the blister and into the dispersion chamber. As a result, the blister remains sealed until the inhaler is ready for use. The blister is then automatically opened when the mouthpiece cover is removed from the mouthpiece. Pharmaceutical dry powder is released from the blister and entrained in air flow through the inhaler, when the user inhales on the mouthpiece. The powder is dispersed in air within the dispersion chamber.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: September 13, 2005
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew E. Young, Stuart Brian William Kay, Neil R Harrison
  • Patent number: 6841910
    Abstract: A magnetic coupling having two opposed annular arrays of angularly spaced permanent magnets magnetized to create magnetic north poles and magnetic south poles alternately spaced about each array. The north-pole and south-pole magnets of each array are tapered in cross-section from their surfaces at the gap to an annular surface of the array spaced from the gap, and permanent magnet spacer magnets completely fill in the space between the north-pole and south-pole magnets from the annular surface of the array at the gap to the spaced annular surface with the spacer magnets being magnetized generally transversely to the direction of magnetization of the adjacent north-pole, south-pole magnets so that the magnetic field created by the permanent magnets extends across the gap and annularly through each array to cause one of the arrays to rotate in synchronism with the other array.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: January 11, 2005
    Assignee: Quadrant Technology Corp.
    Inventor: Jean-Marc Gery
  • Patent number: 6715486
    Abstract: A dry powder inhaler has a dispersion chamber containing beads. A dose of dry powder is released into the chamber, or into an inlet tangentially joining into the chamber. As the patient inhales on a nosepiece or mouthpiece, air moves circularly through the dispersion chamber to drive the beads. The beads roll, bounce, and collide repeatedly with the drug particles on the chamber surfaces or on the beads. The smaller active drug particles are separated from the larger carrier particles and from each other, and a powder aerosol is created and inhaled by the patient. The beads are preferably lightweight, so that they can be rapidly accelerated and moved, even with nominal inspiration. The flow resistance of the inhaler is also reduced via the beads, allowing greater air flow and powder dispersion, without any increased effort by the patient.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: April 6, 2004
    Assignee: Quadrant Technologies Limited
    Inventors: Andrew W. Gieschen, Michael Ligotke, Jeffrey Chen, Charles Ganem, Bernard Greenspan
  • Patent number: 6651655
    Abstract: In a method for creating an immune response, a vaccine is prepared in the form of a dry powder. The powder particles have an aerodynamic particle size range from 1-100 microns. A dose of powder is loaded into a dry powder inhaler. The dose is inhaled with an inspiratory flow rate of less than 60 liters per minute. A mucosal immune response is created via particles of the vaccine material depositing on the upper respiratory tract. A systemic immune response is created via particles of the vaccine material depositing into the deep lung. The vaccine material is size reduced by e.g., jet milling, into the desired range, yet vaccine potency is retained.
    Type: Grant
    Filed: May 2, 2000
    Date of Patent: November 25, 2003
    Assignee: Quadrant Technologies Limited
    Inventors: Cynthia Licalsi, Gary Ward, Bernard Greenspan, Clyde Witham
  • Patent number: 5942962
    Abstract: A dipole magnet structure includes a pair of spaced pole pieces and a pair of permanent magnets secured in alignment with the pole pieces and connected by a magnetically conductive yoke for producing a uniform magnetic field within a predetermined spacial volume therebetween. The opposed faces of the pole pieces are dish-shaped with a flat center area surrounded by an outwardly and forwardly curved rim surface which extends from the center area and which increases in forward curvature as it extends away from the center area to insure homogeneity in the predetermined spacial volume as defined by the space between the pole piece center areas.
    Type: Grant
    Filed: October 2, 1998
    Date of Patent: August 24, 1999
    Assignee: Quadrant Technology
    Inventor: Jean-Marc Gery
  • Patent number: D529604
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: October 3, 2006
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew E. Young, Stuart Brian William Kay, Neil Richard Harrison, Michael W. Ligotke
  • Patent number: D548833
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: August 14, 2007
    Assignee: Quadrant Technologies Limited
    Inventors: Matthew E. Young, Stuart Brian William Kay, Neil Richard Harrison, Michael W. Ligotke